Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
228
-
Total 13F shares, excl. options
-
96,902,244
-
Shares change
-
+5,843,407
-
Total reported value, excl. options
-
$788,823,033
-
Value change
-
+$58,408,431
-
Put/Call ratio
-
27%
-
Number of buys
-
133
-
Number of sells
-
-89
-
Price
-
$8.14
Significant Holders of Xeris Biopharma Holdings, Inc. - COM (XERS) as of Q3 2025
262 filings reported holding XERS - Xeris Biopharma Holdings, Inc. - COM as of Q3 2025.
Xeris Biopharma Holdings, Inc. - COM (XERS) has 228 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 96,902,244 shares
.
Largest 10 shareholders include BlackRock, Inc. (11,927,699 shares), VANGUARD GROUP INC (9,827,917 shares), D. E. Shaw & Co., Inc. (5,839,886 shares), GEODE CAPITAL MANAGEMENT, LLC (4,140,174 shares), STATE STREET CORP (3,738,329 shares), Qube Research & Technologies Ltd (3,274,834 shares), MORGAN STANLEY (3,219,701 shares), Nuveen, LLC (2,827,874 shares), Driehaus Capital Management LLC (2,619,129 shares), and Rosalind Advisors, Inc. (1,795,766 shares).
This table shows the top 228 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.